BC Platforms announced that the Center for Molecular Medicine (CMM) at the Karolinska Institute has extended its research partnership with them to encompass its newest version of the platform and include its BC|GENOME and BC|TILING tools to add capacity for large scale next generation sequencing as well as superior data handling and analytics.
Ingrid Kochum, Senior Researcher at the CMM at Karolinska Institute, said: “We have been using BC Platforms genomic data management tools for over 6 years for our research purposes and are happy to have broadened our collaboration to encompass these new tools to improve the efficiency of our research into common diseases.”
Nino da Silva, EVP Sales and Marketing at BC Platforms, commented: “We are delighted to extend our collaboration with this prestigious institute in order to further their research into major diseases with unmet medical needs. Our tools can help to identify the prevalent markers that indicate a pre-disposition to these diseases and have been used for example in the studies around multiple sclerosis and type 1 diabetes.”
